{"id":"W4386634361","doi":"10.3233/blc-230056","title":"Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"EMD Serono; National Cancer Institute; Natera; Medac; Astellas Pharma; Eisai; Genentech; UroGen Pharma; National Institutes of Health; Incyte; Bristol-Myers Squibb; AstraZeneca; University of Texas MD Anderson Cancer Center; Pfizer; Patient-Centered Outcomes Research Institute","keywords":"Bladder cancer; Medicine; Food and drug administration; Clinical trial; Drug; Intensive care medicine; Oncology; Clinical research; Cancer; Internal medicine; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.5636698,0.001644541,0.003454563,0.003573184,0.00136553,0.0079682,0.004525879,0.006870181,0.01324186],"category_scores_gemma":[0.6496415,0.001602916,0.004127877,0.002366951,0.004621327,0.006219489,0.006002326,0.0106668,0.002338828],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004712041,"about_ca_system_score_gemma":0.021008,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007067406,"about_ca_topic_score_gemma":0.001367054,"domain_scores_codex":[0.307414,0.6619331,0.01643258,0.003846508,0.009126581,0.001247344],"domain_scores_gemma":[0.1750301,0.7280743,0.0339289,0.02489625,0.03140864,0.006661683],"domain_codex":"methods","domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03527809,0.001713116,0.01138425,0.0307958,0.004436887,0.0004816055,0.003440445,0.01702879,0.002257213,0.06960538,0.04537895,0.7781994],"study_design_scores_gemma":[0.08663666,0.03220036,0.01517997,0.04927626,0.006752884,0.0009530096,0.001783799,0.08967402,0.005571621,0.4105511,0.3008688,0.000551438],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.0329087,0.1027965,0.5378419,0.1459679,0.01747002,0.1246506,0.001697446,0.002118249,0.03454867],"genre_scores_gemma":[0.1708534,0.01782903,0.6784515,0.02519225,0.006305279,0.09817395,0.0006117385,0.0002827652,0.002300061],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.5636698,"threshold_uncertainty_score":0.5380728,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1165162165901714,"score_gpt":0.4196531955455624,"score_spread":0.3031369789553909,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}